行动心臟遥测市场规模、份额和成长分析（按应用、类型和地区）- 产业预测 2025-2032

预计 2023 年全球行动心臟遥测市场规模将达到 10 亿美元，并从 2024 年的 10.1 亿美元成长到 2032 年的 25.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 12.1%。

移动心臟遥测 (MCT) 系统是动态心臟监测领域的一个重要进步，它降低了门诊病人心电图诊断成本并提供即时分析。这种可携式设备使患者和医生都受益，并提高了护理效率。心血管疾病 (CVD) 盛行率的上升和老年人口的增加推动了 MCT 系统市场的成长。心臟疾病和脑血管疾病，是世界范围内的主要死亡原因之一，是由吸烟、不良饮食等不良生活习惯引起的。 MCT 系统由穿戴式感测器组成，可主动监测患者并立即将资料传输到集中分析中心，为医疗保健专业人员提供及时的见解。这些技术的整合有望改善诊断和管理，使 MCT 系统成为现代医疗保健的重要工具。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

移动心臟遥测市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 铅基
• 基于补丁

移动心臟遥测市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 医院
• 心臟中心
• 其他的

移动心臟遥测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic plc（Ireland）
• Koninklijke Philips NV（Netherlands）
• iRhythm Technologies, Inc.（USA）
• Preventice Solutions（USA）
• Boston Scientific Corporation（USA）
• ScottCare Corporation（USA）
• Applied Cardiac Systems, Inc.（USA）
• Medicomp, Inc.（USA）
• CardioNet, Inc.（USA）
• LifeWatch AG（Switzerland）
• Bittium Corporation（Finland）
• GE Healthcare（USA）
• Siemens Healthineers AG（Germany）
• Hillrom Holdings, Inc.（USA）
• Baxter International Inc.（USA）
• AliveCor, Inc.（USA）
• InfoBionic, Inc.（USA）

结论和建议

Global Mobile Cardiac Telemetry Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.01 billion in 2024 to USD 2.52 billion by 2032, growing at a CAGR of 12.1% during the forecast period (2025-2032).

Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in ambulatory cardiac monitoring, offering real-time analysis and reducing electrocardiographic diagnosis costs for outpatients. These portable devices benefit both patients and physicians, enhancing care efficiency. The increasing prevalence of cardiovascular diseases (CVDs), alongside a growing geriatric population, is fueling market growth for MCT systems. CVDs, including coronary heart disease and cerebrovascular conditions, are the leading global cause of mortality, exacerbated by lifestyle factors like tobacco use and poor diet. MCT systems consist of wearable sensors that actively monitor patients and instantly transmit data to a centralized analysis center, providing timely insights for healthcare professionals. This integration of technology promises improved diagnosis and management, positioning MCT systems as essential tools in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mobile Cardiac Telemetry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mobile Cardiac Telemetry Market Segmental Analysis

Global Mobile Cardiac Telemetry Market is segmented by Application, Type and region. Based on Application, the market is segmented into lead based and patch based. Based on Type, the market is segmented into Hospitals, cardiac centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is significantly driven by advancements in healthcare technology that enhance patient monitoring capabilities. Growing awareness of innovative patch technology, alongside the launch of devices with improved functionalities, plays a crucial role in fueling this market's expansion. A key factor contributing to the rise of mobile cardiac telemetry (MCAT) systems is the alarming increase in mortality rates associated with cardiovascular diseases, exacerbated by widespread unhealthy lifestyle choices, including sedentary behavior, obesity, and tobacco use. Additionally, the heightened utilization of MCAT devices for the quick identification of arrhythmogenic risks, especially among COVID-19 patients in outpatient settings, further propels market growth.

Restraints in the Global Mobile Cardiac Telemetry Market

The global mobile cardiac telemetry market is likely to face significant restraints in the coming years, predominantly due to the high costs associated with advanced telemetry devices. This financial barrier may limit widespread adoption of mobile cardiovascular telemetry systems, ultimately hindering market growth during the forecast period. Additionally, stringent regulatory requirements and the potential for product recalls stemming from failures could further restrict revenue growth in this sector. As a result, these challenges may pose considerable obstacles for the mobile cardiac telemetry market, impacting its ability to expand effectively and reach its full potential in the healthcare industry.

Market Trends of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is witnessing substantial growth driven by advancements in technology that enhance patient monitoring capabilities. The increasing demand for non-invasive, remote healthcare solutions is propelling the adoption of mobile cardiac telemetry systems, enabling patients to maintain mobility while seamlessly transmitting real-time physiological data to healthcare providers. This innovation not only facilitates timely diagnosis and intervention but also aligns with the growing trend towards personalized medicine and chronic disease management. As healthcare systems embrace telehealth solutions, the market is poised for remarkable expansion, reflecting greater reliance on data-driven approaches to improve patient outcomes and operational efficiencies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Mobile Cardiac Telemetry Market Size by Application & CAGR (2025-2032)

• Market Overview
• lead based
• patch based

Global Mobile Cardiac Telemetry Market Size by Type & CAGR (2025-2032)

• Market Overview
• Hospitals
• cardiac centres
• others

Global Mobile Cardiac Telemetry Market Size & CAGR (2025-2032)

• North America (Application, Type)
  • US
  • Canada
• Europe (Application, Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iRhythm Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Preventice Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScottCare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Cardiac Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicomp, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioNet, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeWatch AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bittium Corporation (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hillrom Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InfoBionic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations